AD	Alzheimer’s disease
ADHD	attention deficit hyperactivity disorder
ASD	autism spectrum disorders
AUC	area under the curve
AUD	alcohol use disorder
BDNF	brain-derived neurotrophic factor
BPD	bipolar disorder
CBD	cannabidiol
CNS	central nervous system
DMT	N,N-dimethyltryptamine
DSM-V	Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
FDA	Food and Drug Administration
fMRI	functional magnetic resonance imaging
FRA	flexible docking mode
GDNF	glial cell line-derived neurotrophic factor
5-HT	serotonin
IND	investigational new drug
iPSC	induced pluripotent stem cells
LSD	D-lysergic acid diethylamide
MADRS	Montgomery–Åsberg Depression Rating Scale
mGluR	metabotropic glutamate receptor
mTOR	mammalian target rapamycin receptor
NIH	National Institutes of Health
NGF	neural growth factor
NMDA	N-methyl-D-aspartate
NSSs	neurotransmitter sodium symporters
6-OHDA	6-hydroxydopamine
OUD	opioid use disorder
PAP	assisted psychotherapy
PD	Parkinson’s disease
PDB	protein data bank
PET	positron emission tomography
PG	prostaglandin
PTSD	post-traumatic stress disorder
RMSF	root-mean-square-fluctuation
RRA	rigid docking mode
SERT	serotonin transporter
STAI	state-trait anxiety inventory
SV2A	synaptic vesicle glycoprotein 2A
TAARs	trace amine associated receptors
TrkB	tropomyosin kinase B
VMAT2	vesicular monoamine transporter 2
VTA	ventral tegmental area